Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis

被引:18
作者
Berning, Philipp [1 ]
Schmitz, Norbert [1 ]
Ngoya, Maud [2 ]
Finel, Herve [2 ]
Boumendil, Ariane [2 ]
Wang, Fengrong [3 ]
Huang, Xiao-Jun [3 ]
Hermine, Olivier [4 ]
Philippe, Laure [4 ]
Couronne, Lucile [5 ]
Jaccard, Arnaud [6 ]
Liu, Daihong [7 ]
Wu, Depei [8 ]
Reinhardt, Hans Christian [9 ]
Chalandon, Yves [10 ,11 ]
Wagner-Drouet, Eva
Kwon, Mi
Zhang, Xi
Carpenter, Ben
Yakoub-Agha, Ibrahim
Wulf, Gerald
Lopez-Jimenez, Javier
Sanz, Jaime
Labussiere-Wallet, Helene
Shimoni, Avichai
Dreger, Peter
Sureda, Anna
Kim, Won Seog
Glass, Bertram
机构
[1] Univ Hosp Muenster, Dept Hematol & Oncol, Munster, Germany
[2] Hop St Antoine, European Soc Blood & Marrow Transplantat, Paris, France
[3] Beijing Univ, Inst Hematol, Natl Clin Res Ctr Hematol Dis, Beijing, Peoples R China
[4] Univ Paris 05, Hop Necker, AP HP, Dept Hematol, Paris, France
[5] Univ Paris Cite, Necker Childrens Hosp, APHP, Lab Oncohematol, Paris, France
[6] CHU Dupuytren, Dept Hematol, Limoges, France
[7] Gen Hosp Peoples Liberat Army China, Beijing, Peoples R China
[8] Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Affiliated Hosp 1, Suzhou, Peoples R China
[9] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, Essen, Germany
[10] Univ Geneva, Hop Univ Geneve, Div Hematol, Geneva, Switzerland
[11] Univ Geneva, Fac Med, Geneva, Switzerland
关键词
MATURE T-CELL; NASAL-TYPE; RETROSPECTIVE ANALYSIS; MULTICENTER; CHEMOTHERAPY; OUTCOMES; SMILE; GUIDELINES; DIAGNOSIS; BLOCKADE;
D O I
10.1038/s41375-023-01924-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer/T-cell lymphomas (NKTCL) represent rare and aggressive lymphoid malignancies. Patients (pts) with relapsed/refractory disease after Asparaginase (ASPA)-based chemotherapy have a dismal prognosis. To better define the role of allogeneic hematopoietic stem cell transplantation (allo-HSCT), we conducted a retrospective analysis of data shared with the European Society for Blood and Marrow Transplantation (EBMT) and cooperating Asian centers. We identified 135 pts who received allo-HSCT between 2010 and 2020. Median age was 43.4 years at allo-HSCT, 68.1% were male. Ninety-seven pts (71.9 %) were European, 38 pts (28.1%) Asian. High Prognostic Index for NKTCL (PINK) scores were reported for 44.4%; 76.3% had >1 treatment, 20.7% previous auto-HSCT, and 74.1% ASPA-containing regimens prior to allo-HSCT. Most (79.3%) pts were transplanted in CR/PR. With a median follow-up of 4.8 years, 3-year progression-free(PFS) and overall survival were 48.6% (95%-CI:39.5-57%) and 55.6% (95%-CI:46.5-63.8%). Non-relapse mortality at 1 year was 14.8% (95%-CI:9.3-21.5%) and 1-year relapse incidence 29.6% (95%-CI:21.9-37.6%). In multivariate analyses, shorter time interval (0-12 months) between diagnosis and allo-HSCT [HR = 2.12 (95%-CI:1.03-4.34); P = 0.04] and transplantation not in CR/PR [HR = 2.20 (95%-CI:0.98-4.95); P = 0.056] reduced PFS. Programmed cell death protein 1(PD-1/PD-L1) treatment before HSCT neither increased GVHD nor impacted survival. We demonstrate that allo-HSCT can achieve long-term survival in approximately half of pts allografted for NKTCL.
引用
收藏
页码:1511 / 1520
页数:10
相关论文
共 40 条
[1]   The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms [J].
Alaggio, Rita ;
Amador, Catalina ;
Anagnostopoulos, Ioannis ;
Attygalle, Ayoma D. ;
Araujo, Iguaracyra Barreto de Oliveira ;
Berti, Emilio ;
Bhagat, Govind ;
Borges, Anita Maria ;
Boyer, Daniel ;
Calaminici, Mariarita ;
Chadburn, Amy ;
Chan, John K. C. ;
Cheuk, Wah ;
Chng, Wee-Joo ;
Choi, John K. ;
Chuang, Shih-Sung ;
Coupland, Sarah E. ;
Czader, Magdalena ;
Dave, Sandeep S. ;
de Jong, Daphne ;
Du, Ming-Qing ;
Elenitoba-Johnson, Kojo S. ;
Ferry, Judith ;
Geyer, Julia ;
Gratzinger, Dita ;
Guitart, Joan ;
Gujral, Sumeet ;
Harris, Marian ;
Harrison, Christine J. ;
Hartmann, Sylvia ;
Hochhaus, Andreas ;
Jansen, Patty M. ;
Karube, Kennosuke ;
Kempf, Werner ;
Khoury, Joseph ;
Kimura, Hiroshi ;
Klapper, Wolfram ;
Kovach, Alexandra E. ;
Kumar, Shaji ;
Lazar, Alexander J. ;
Lazzi, Stefano ;
Leoncini, Lorenzo ;
Leung, Nelson ;
Leventaki, Vasiliki ;
Li, Xiao-Qiu ;
Lim, Megan S. ;
Liu, Wei-Ping ;
Louissaint, Abner, Jr. ;
Marcogliese, Andrea ;
Medeiros, L. Jeffrey .
LEUKEMIA, 2022, 36 (07) :1720-1748
[2]   Defining the Intensity of Conditioning Regimens: Working Definitions [J].
Bacigalupo, Andrea ;
Ballen, Karen ;
Rizzo, Doug ;
Giralt, Sergio ;
Lazarus, Hillard ;
Ho, Vincent ;
Apperley, Jane ;
Slavin, Shimon ;
Pasquini, Marcelo ;
Sandmaier, Brenda M. ;
Barrett, John ;
Blaise, Didier ;
Lowski, Robert ;
Horowitz, Mary .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (12) :1628-1633
[3]   Use of checkpoint inhibitors in patients with lymphoid malignancies receiving allogeneic cell transplantation: a review [J].
Bobillo, Sabela ;
Camilo Nieto, Juan ;
Barba, Pere .
BONE MARROW TRANSPLANTATION, 2021, 56 (08) :1784-1793
[4]   Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome [J].
Castagna, Luca ;
Pagliardini, Thomas ;
Bramanti, Stefania ;
Schiano de Colella, Jean Marc ;
Montes de Oca, Catalina ;
Bouabdallah, Reda ;
Mariotti, Jacopo ;
Furst, Sabine ;
Granata, Angela ;
De Philippis, Chiara ;
Harbi, Samia ;
Sarina, Barbara ;
Legrand, Faezeh ;
Maisano, Valerio ;
Weiller, Pierre Jean ;
Chabannon, Christian ;
Carlo-Stella, Carmelo ;
Santoro, Armando ;
Blaise, Didier ;
Devillier, Raynier .
BONE MARROW TRANSPLANTATION, 2021, 56 (04) :883-889
[5]   Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation [J].
Cwynarski, Kate ;
van Biezen, Anja ;
de Wreede, Liesbeth ;
Stilgenbauer, Stephan ;
Bunjes, Donald ;
Metzner, Bernd ;
Koza, Vladimir ;
Mohty, Mohamad ;
Remes, Kari ;
Russell, Nigel ;
Nagler, Arnon ;
Scholten, Marijke ;
de Witte, Theo ;
Sureda, Anna ;
Dreger, Peter .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) :2211-2217
[6]   Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro [J].
d'Amore, F. ;
Gaulard, P. ;
Truemper, L. ;
Corradini, P. ;
Kim, W. -S. ;
Specht, L. ;
Pedersen, M. Bjerregaard ;
Ladetto, M. .
ANNALS OF ONCOLOGY, 2015, 26 :V108-V115
[7]   Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type [J].
Ennishi, Daisuke ;
Maeda, Yoshinobu ;
Fujii, Nobuharu ;
Kondo, Eisei ;
Shinagawa, Katsuji ;
Ikeda, Kazuma ;
Ichimura, Koichi ;
Yoshino, Tadashi ;
Tanimoto, Mitsune .
LEUKEMIA & LYMPHOMA, 2011, 52 (07) :1255-1261
[8]   Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics [J].
Hamadani, Mehdi ;
Ngoya, Maud ;
Sureda, Anna ;
Bashir, Qaiser ;
Litovich, Carlos Alejandro ;
Finel, Herve ;
Chen, Yue ;
Boumendil, Ariane ;
Zain, Jasmine ;
Castagna, Luca ;
Cashen, Amanda F. ;
Blaise, Didier ;
Shadman, Mazyar ;
Pastano, Rocco ;
Khimani, Farhad ;
Arat, Mutlu ;
Dietrich, Sascha ;
Schmitz, Norbert ;
Glass, Bertram ;
Kharfan-Dabaja, Mohamed A. ;
Corradini, Paolo ;
Sauter, Craig S. ;
Montoto, Silvia ;
Kwon, Mi ;
Herrera, Alex F. ;
Dreger, Peter .
BLOOD ADVANCES, 2022, 6 (03) :920-930
[9]   PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD [J].
Haverkos, Bradley M. ;
Abbott, Diana ;
Hamadani, Mehdi ;
Armand, Philippe ;
Flowers, Mary E. ;
Merryman, Reid ;
Kamdar, Manali ;
Kanate, Abraham Sebastian ;
Saad, Ayman ;
Mehta, Amitkumar ;
Ganguly, Siddhartha ;
Fenske, Timothy S. ;
Hari, Parameswaran ;
Lowsky, Robert ;
Andritsos, Leslie ;
Jagasia, Madan ;
Bashey, Asad ;
Brown, Stacey ;
Bachanova, Veronika ;
Stephens, Deborah ;
Mineishi, Shin ;
Nakamura, Ryotaro ;
Chen, Yi-Bin ;
Blazar, Bruce R. ;
Gutman, Jonathan ;
Devine, Steven M. .
BLOOD, 2017, 130 (02) :221-228
[10]   Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma [J].
Herbaux, Charles ;
Gauthier, Jordan ;
Brice, Pauline ;
Drumez, Elodie ;
Ysebaert, Loic ;
Doyen, Helene ;
Fornecker, Luc ;
Bouabdallah, Krimo ;
Manson, Guillaume ;
Ghesquieres, Herve ;
Tabrizi, Reza ;
Hermet, Eric ;
Lazarovici, Julien ;
Thiebaut-Bertrand, Anne ;
Chauchet, Adrien ;
Demarquette, Helene ;
Boyle, Eileen ;
Houot, Roch ;
Yakoub-Agha, Ibrahim ;
Morschhauser, Franck .
BLOOD, 2017, 129 (18) :2471-2478